Abstract
Current rat calcitonin immunoassays use human calcitonin antisera, and suffer from poor sensitivity, long incubation periods, nonspecific interferences, and unreliability. The homologous immunoradiometric assay (IRMA) for rat calcitonin described here overcomes these problems. Overnight incubation yields a detection limit of 0.4 pg/mL, a standard curve that is linear to >1800 pg/mL, and intra- and interassay coefficients of variation of <7%. Gel filtration chromatography of rat plasma and rat medullary thyroid carcinoma 44-2 cell media showed that the vast majority of immunoreactivity coeluted with calcitonin standard. In 44-2 cells, increasing extracellular Ca2+ concentration or incubation with the calcimimetic compound NPS R-467 markedly increased calcitonin secretion. Plasma calcitonin levels were elevated in rats anesthetized with ketamine/xylazine and in conscious rats with chronic renal insufficiency. Calcitonin levels decreased following EGTA-induced hypocalcemia and were undetectable after thyroparathyroidectomy. In normal conscious rats, plasma calcitonin levels averaged 3–5 pg/mL and increased up to 100-fold following calcium (Ca) infusion or NPS R-467 administration. The assay also quantified calcitonin in plasma of normal and Ca-injected mice. This assay has revealed that plasma calcitonin levels in normal rats are much lower than the detection limits of most existing assays, but can increase by 100-fold on activation of the C-cell Ca2+ receptor.
Similar content being viewed by others
References
Broadus, A. E. (1996). In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd Ed. Favus, M. J. (ed.). Lippincott-Raven: Philadelphia, pp., 57–63.
Deftos, L. J. (1996). In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd Ed. Favus, M. J. (ed.). Lippincott-Raven: Philadelphia, pp., 82–87.,
Becker, K. L., Nylén, E. S., Cohen, R., and Snider, R. H., Jr. (1996). In: Principles of Bone Biology, Bilezekian, J. P., Raisz, L. G., and Rodan, G. A. (eds.). Academic: San Diego, pp. 471–494.
Cooper, C. W., Hirsch, P. F., and Munson, P. L. (1970). Endocrinology 86, 406–415.
Yamamoto, M., Seedor, J. G., Rodan, G. A., and Balena, R. (1995). Endocrinology 136, 788–795.
Austin, L. A. and Heath, H., III. (1981). N. Engl. J. Med. 304, 269–278.
Brown, E. M., Gamba, G., Riccardi, D., Lombardi, M., Butters, R., Kifor, O., et al. (1993). Nature 366, 575–580.
Garrett, J. E., Capuano, I. V., Hammerland, L. G., Hung, B. C. P., Brown, E. M., Hebert, S. C., et al. (1995). J. Biol. Chem. 270, 12,919–12,925.
Garrett, J. E., Tamir, H., Kifor, O., Simin, R. T., Rogers, K. V., Mithal, A., et al. (1995). Endocrinology 136, 5202–5211.
Nemeth, E. F. (1996). In: Principles of Bone Biology, Bilezekian, J. P., Raisz, L. G., and Rodan, G. A. (eds.). Academic: San Diego, pp. 1019–1035.
Nemeth, E. F., Steffey, M. E., Hammerland, L. G., Hung, B. C. P., Van Wagenen, B. C., Delmar, E. G., et al. (1998). Proc. Natl. Acad. Sci. USA 95, 4040–4045.
Fox, J., Hadfield, S., Petty, B. A., and Nemeth, E. F. (1993). J. Bone Miner. Res. 8(Suppl. 1), S181 (Abstract).
Fox, J., Hadfield, S., Petty, B. A., Conklin, R. L., and Nemeth, E. F. (1993). J. Am. Soc. Nephrol. 4, 719 (Abstract).
Raue, F., Deutschle, I., Küntzel, C., and Ziegler, R. (1984). Endocrinology 115, 2362–2367.
Feinstein, R. E., Bucht, E., Grimelius, L., Iwarsson, K., Rönnbäck, C., and Sjöberg, H.-E. (1989). Acta Endocrinol. (Copenh.) 120, 210–214.
Fox, J. (1988). Am. J. Physiol. 255, E702-E707.
Deftos, L. J., Roos, B. A., Bronzert, D., and Parthemore, J. G., (1975). J. Clin. Endocrinol. Metab. 40, 409–412.
Body, J.-J. and Heath H., III. (1983). J. Clin. Endocrinol. Metab. 57, 897–903.
Antonsen, J. E., Sherrard, D. J., and Andress, D. L. (1998). Kidney Int. 53, 223–227.
Rehli, M., Luger, K., Beier, W., and Falk, W. (1996). Biochem. Biophys. Res. Commun. 226, 420–425.
Kovacs, C. S., Ho-Pao, C. L., Hunzelman, J. L., Lanske, B., Fox, J., Seidman, J. G., et al. (1998). J. Clin. Invest. 101, 2812–2820.
Burford, H. J., Ontjes, D. A., Cooper, C. W., Parlow, A. F., and Hirsch, P. F. (1975). Endocrinology 96, 340–348.
Raulais, D., Hagaman, J., Ontjes, D. A., Lundblad, R. L., and Kingdon H. S. (1976). Eur. J. Biochem. 64, 607–611.
Heath, H. III., Body, J.-J., and Fox, J. (1984). Biomed. Pharmacother. 38, 214–245.
Okumura, K., Saito, Y., Yasuhara, M., and Hori, R. (1984). J. Pharm. Dynamics 7, 917–922.
Schultz, V. L., Boass, A., Garner, S. C., and Toverud, S. U. (1995). J. Bone Miner. Res. 10, 1298–1302.
Wixson, S. K., White, W. J., Hughes, H. C., Jr., Lang, C. M., and Marshall W. K. (1987). Lab. Anim. Sci. 37, 736–742.
Ardaillou, R. (1975). Nephron 15, 250–260.
Mithal, A., Kifor, O., Kifor, I., Vassilev, P., Butters, R., Krapcho, K., et al. (1995). Endocrinology 136, 3087–3092.
Nemeth, E. F. (1990). Cell Calcium 11, 323–327.
Kifor, O., Diaz, R., Butters, R., and Brown, E. M. (1997). J. Bone Miner. Res. 12, 715–725.
Schultz, V. L., Garner, S. C., Lavigne, J. R., and Toverud, S. U. (1994). Bone Miner. 27, 121–132.
Rucinski, B., Mann, G. N., and Epstein, S. (1995). Calcif. Tissue Int. 56, 83–87.
Reichlin, M. (1980). Methods Enzymol. 70, 159–165.
Hunter, W. M. and Budd, P. S. (1981). J. Immunol. Methods 45, 255–273.
Fox, J. (1990). Horm. Metab. Res. 22, 278–282.
Rogers, K. V. and Fox, J. (1995). Endocrine 3, 769–774.
Author information
Authors and Affiliations
Corresponding author
Additional information
The rat calcitonin assay described in this paper is available as a kit from Immutopics, Inc., 929 Calle Negocio, Suite A, San Clemente, CA 92673.
Rights and permissions
About this article
Cite this article
Lavigne, J.R., Zahradnik, R.J., Conklin, R.L. et al. Stimulation of calcitonin secretion by calcium receptor activators. Endocr 9, 293–301 (1998). https://doi.org/10.1385/ENDO:9:3:293
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:9:3:293